Not a bad idea. I might put an order in around .73 myself and let is sit there just incase. Their deal with Pierre Fabre Labs is solid and worth a pretty penny. With the launch of the drug in the EU they should start to see some revenue coming in soon enough off that. Then lets get FDA approval for Tab Cel. This reminds me of CPRX. That one got let for dead. They got approval on Ferdap and it blew up and revenues started to really take off.
News 
Market Data 
Discover 
